comparemela.com
Home
Live Updates
Clinical Scientific Consultant - Breaking News
Pages:
Latest Breaking News On - Clinical scientific consultant - Page 1 : comparemela.com
Gain Therapeutics Announces Dosing of First Two Subjects in Phase 1 Clinical Trial of GT-02287, a Novel GCase-targeting Small Molecule Therapy for GBA1 Parkinson s Disease
First small molecule allosteric binder discovered with Gain’s computational drug discovery platform enters clinical developmentBETHESDA, Md., Oct. 04, 2023 Gain Therapeutics, Inc. , a.
Matthias alder
Susan sharpe
Exchange commission
Silverstein foundation for parkinson
Company annual report on form
National gaucher foundation
Michaelj fox foundation for parkinson research
Treatment initiative
Linnden communications
Exchange commission on
Gain therapeutics inc
Chief executive officer
Robin ely
Regenerative medicine
Clinical scientific consultant
Silverstein foundation
vimarsana © 2020. All Rights Reserved.